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Available online 27 September 2013Abstract The direct lineage reprogramming of somatic cells to other lineages by defined factors has led to innovative
cell-fate-change approaches for providing patient-specific cells. Recent reports have demonstrated that four pluripotency factors
(Oct4, Sox2, Klf4, and c-Myc) are sufficient to directly reprogram fibroblasts to other specific cells, including induced neural stemcells
(iNSCs). Here, we show that mouse fibroblasts can be directly reprogrammed into midbrain dopaminergic neuronal progenitors (DPs)
by temporal expression of the pluripotency factors and environment containing sonic hedgehog and fibroblast growth factor 8. Within
thirteen days, self-renewing and functional induced DPs (iDPs) were generated. Interestingly, the inhibition of both Jak and Gsk3β
notably enhanced the iDP reprogramming efficiency. We confirmed the functionality of the iDPs by showing that the dopaminergic
neurons generated from iDPs express midbrain markers, release dopamine, and show typical electrophysiological profiles. Our results
demonstrate that the pluripotency factors-mediated direct reprogramming is an invaluable strategy for supplying functional and
proliferating iDPs and may be useful for other neural progenitors required for disease modeling and cell therapies for
neurodegenerative disorders.
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Open access undIntroduction
Induced pluripotent stem cells (iPSCs) and cellular repro-
gramming technology (Takahashi et al., 2007; Takahashi and
Yamanaka, 2006) provide tremendous potential in disease
modeling, cell therapy, and regenerative medicine, likely
leading to a personalized approach. Recent advances have
shown that the fate of a cell type can be directly changeder the CC BY-NC-ND license.
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pre-determined reprogramming factors without generating
pluripotent cells (Sancho-Martinez et al., 2012; Liu et al.,
2012a). The directly reprogrammed cells exhibit equivalent
functionality to the differentiated cells from pluripotent
cells and their in vivo counterparts and also show no
tumorigenicity when they are transplanted in vivo (Liu et
al., 2012a; Matsui et al., 2012).
Most direct lineage reprogramming strategies use factors
that show specific expression in target cells. In contrast, the
pluripotency factor-mediated direct reprogramming (PDR)
strategy (Kim et al., 2012) uses the same pluripotency
factors as iPSC reprogramming. During PDR, flexible inter-
mediate cell types are generated, and those intermediates
can be further specified into various tissue-specific target
cells under specific conditions (Kim et al., 2011a, 2012; Efe
et al., 2011).
Parkinson's disease (PD) is a neurological disorder character-
ized by the degeneration of dopaminergic neurons in the
midbrain substantia nigra, leading to a reduction of dopamine in
the striatum (Gaillard and Jaber, 2011). Currently, dopaminer-
gic neurons can be obtained through differentiation from
pluripotent cells (Ganat et al., 2012). Recently, the direct
conversion of fibroblasts also generates personalized induced
dopaminergic neurons (Pfisterer et al., 2011; Caiazzo et al.,
2011; Liu et al., 2012b; Kim et al., 2011b). However, the
terminally differentiated induced neurons are not adequate for
transplantation (Rhee et al., 2011). Progenitors or precursors
should be advantageous in handling and obtaining the cells
in vitro as well as in proper integration in vivo.
Thus, we hypothesized that dopaminergic progenitors/
precursors (DPs) also can be generated by direct lineage
reprogramming. As the PDR approach can generate prolifer-
ating neural stem cells (NSCs) under appropriate environ-
mental conditions (Liu et al., 2012a; Kim et al., 2011a; Wang
et al., 2012; Thier et al., 2012; Han et al., 2012; Lu et al.,
2013), we assumed that DPs, which are further specified
than general NSCs but not fully differentiated into neurons,
can be generated under appropriately modified environ-
mental conditions by PDR. Here, we showed that mouse
fibroblasts can be directly reprogrammed into midbrain-
specific DPs through the transient expression of the four
Yamanaka factors under dopaminergic neuron-specific and
intermediate cell-enriching conditions. This work demon-
strates direct cell fate alteration from fibroblast to specific
neural progenitors through PDR strategy and provides
another novel route for obtaining useful progenitors for
potential therapies and studies on various neural diseases.Materials and methods
Direct reprogramming and differentiation
Reprogrammable MEFs were prepared as previously described
(Kim et al., 2011a) and used for direct reprogramming
into dopaminergic progenitors. The cells were plated on
Matrigel-coated culture dishes at 2 × 104 cells/cm2 in
Dulbecco's modified Eagle's medium (DMEM) containing 10%
FBS, 1% nonessential amino acids (NEAA), and 1% penicillin/
streptomycin. On the next day (D1), the cells were cultured
in reprogramming initiation medium containing 10% knock-out serum replacer, 5% FBS, 1% NEAA, 2 mM Glutamax,
and 0.055 mM β-mercaptoethanol in knock-out DMEM for
4 days. Doxycycline (Dox) (Sigma, St. Louis, MO, USA) was
included in media from the first day (D0) to day five (D5).
For reprogramming to iDPs, the medium was changed
to RepM-DP containing 1 × N2, 1 × B27, 0.05% BSA, 2 mM
Glutamax, 0.11 mM β-mercaptoethanol, 200 ng/mL SHH
(Peprotech, Rocky Hill, NJ, USA), and 100 ng/mL FGF8b
(Peprotech) in advanced DMEM/F12 and neurobasal medium
(1:1 mix) for the next 8 days. For reprogramming to iNSCs,
the cells were cultured in RepM-Neural, as previously
reported (Kim et al., 2011a). For neuronal differentiation,
NSC-like colonies were selected and dissociated into single
cells with Accutase (Millipore, Billerica, MA, USA) and
plated on poly-ornithine/laminin-coated culture dishes in
differentiation medium containing 1 × N2, 1 × B27, 1.0 mM
Glutamax, 0.11 mM β-mercaptoethanol, 1.0 mM dibutyryl-
cAMP (Enzo), 0.2 mM ascorbic acid (Sigma), 10 ng/mL brain-
derived neurotrophic factor (BDNF) (Peprotech), and 10 ng/mL
glial cell line-derived neurotrophic factor (GDNF) (Peprotech)
in DMEM/F12. The medium was changed every 3–4 days.
Unless otherwise indicated, all reagents were purchased
from Invitrogen (Carlsbad, CA, USA).
Quantitative RT-PCR
Total RNA was extracted from cultured cells using Trizol
reagent (Invitrogen). cDNA was synthesized from 1 μg of
total RNA using the SuperScript III Reverse Transcriptase Kit
(Invitrogen) and oligo(dT) primers (Invitrogen) according to
the manufacturer's instructions. Quantitative polymerase
chain reaction (PCR) was performed with Power SYBR
Green Master Mix (Takara Bio Inc., Shiga, Japan) and
analyzed using the 7500 Fast Real-Time PCR system (Applied
Biosystems). The primers used are listed in supplementary
material Table S2.
Immunocytochemistry
The cultured cells were immersed in 4% formaldehyde (Electron
Microscopy Sciences, Ft.Washington, PA, USA) in PBS for 10 min
and washed with PBS four times. The fixed cells were blocked
and permeabilized with 0.3% Triton X-100, 10% FBS, and 1% BSA
in PBS for 1 h at room temperature. After washing with PBS
three times, the cells were incubated with primary antibody in
blocking solution (PBS containing 10% FBS and 1% BSA) for 1 h.
The primary antibodies are listed in supplementary material
Table S3. After the primary antibody reaction, the cells
were washed with PBS three times and incubated for 1 h
at room temperature in PBS containing 1% BSA with anti-
mouse Alexa 488-conjugated (1:500, Invitrogen), anti-mouse
Alexa 546-conjugated (1:500, Invitrogen), anti-rabbit Alexa
488-conjugated (1:500, Invitrogen), or anti-rabbit Alexa 546-
conjugated (1:500, Invitrogen) secondary antibodies. Fluores-
cent images were obtained using an Axio Vert.A1 microscope
(Carl Zeiss, Oberkochen, Germany).
Dopamine enzyme-linked immunosorbent assay
After 14 days of differentiation into dopaminergic neurons
from neural precursor cells, the examination of dopamine
62 H.-S. Kim et al.release was performed as previously described (Trzaska et
al., 2007). Briefly, cells plated on a 24 well dish were
washed with PBS then incubated in 200 μL of a low-KCl
(4.5 mM) solution or 200 μL of a high-KCl (56 mM) solution
for 10 min. Levels of dopamine in supernatants were quantified
by using an enzyme-linked immunosorbent assay kit obtained
from Rocky Mountain Diagnostics (Colorado, USA) according to
the manufacturer's instructions.Electrophysiology
The method of whole-cell patch-clamp recording has been
described previously (Jung et al., 2012). Cells plated on
coverslips were placed in a submerged recording chamber and
constantly perfusedwith oxygenated (95%O2, 5% CO2), artificial
cerebrospinal fluid (ACSF, 124 mM NaCl, 3.0 mM KCl, 1.23 mM
NaH2PO4, 2.2 mM CaCl2, 1.2 mM MgCl2, 26 mM NaHCO3, and
10 mM glucose, pH 7.4). Whole-cell recordings were performed
at 31 °C using glass pipette electrodes (3–5 MΩ). To measure
action potentials (APs), glass pipettes were filled with an
internal solution (135 mM K-gluconate, 5 mM KCl, 2 mM MgCl2,
5 mM EGTA, 10 mM HEPES, 0.5 mM CaCl2, 5 mM Mg-ATP, and
0.3 mM Na-GTP) which was buffered to pH 7.4 with KOH.
Resting membrane potential was estimated immediately after
breaking the membrane and establishing a whole-cell configu-
ration. APs were triggered by a step-current injection (10 pA
steps) in current clamp mode for 500 ms. The threshold,
amplitude, half-width, and after hyperpolarization (AHP) of the
1st AP were analyzed. Spontaneous firings were measured with
0 pA-current injection, and rebound APs were induced by brief
injections of hyperpolarizing current (−20 pA). To block APs,
1 μM tetrodotoxin (TTX) was used. Patch-clamp recordings
were performed using a MultiClamp 700B amplifier and a
Digidata 1440 (Axon Instruments), and the acquired data were
analyzed using the pCLAMP version 10.2 (Axon Instruments) and
the Mini-Analysis Program (Synaptosoft) (Jung et al., 2012; Jeon
et al., 2008).Lentivirus preparation and reprogramming mouse
tail tip fibroblasts (TTFs)
Lentiviral infection was performed as described previously
(Kim et al., 2011a). Briefly, 293T cells were transfected
with 8 μg pHAGE2-TetOminiCMV-STEMCCA or FUW-M2rtTA
(Addgene) along with a packaging mixture (5 μg psPAX2
and 2.5 μg pMD2.G) (Addgene) and FuGENE HD transfection
reagent (Promega, Madison, WI, USA) according to the
manufacturer's instructions. TTF cells were prepared as
previously described (Kim et al., 2011a). After transduction
with STEMCCA and rtTA-expressing virus, the cells were
reprogrammed according to the procedure used for repro-
grammable MEFs.Statistical analysis
The results are presented as the mean ± s.e.m. Student's
unpaired t-test was used for statistical evaluation, with p
values of 0.01 or 0.001 as the level of significance.Results and discussion
Dopaminergic progenitors are directly reprogrammed
from mouse fibroblasts
During PDR, the lineage-specific commitment to target cells of
interest is largely dependent on environmental cues (Liu et al.,
2012a; Kim et al., 2011a, 2012; Efe et al., 2011). Thus, to
advance and expand the PDR approach to new target cell
types, it is crucial to determine the appropriate environmental
conditions. Accordingly, we attempted to determine which
environmental factors were specifically required for direct
reprogramming to DPs, as these factors were expected to be
different from those to enable the reprogramming to iNSCs.
Similar to the direct reprogramming to iNSCs (Kim et al.,
2011a), the reprogrammable MEFs were used to induced
dopaminergic progenitors/precursors (iDPs) to tightly control
the expression of the four Yamanaka factors and enhance the
homogeneity of the entire process. As a novel approach, we
determined whether sonic hedgehog (SHH) and fibroblast
growth factor 8 (FGF8), important morphogens for midbrain
development that are generally used in differentiation to
ventral midbrain dopaminergic neurons (Cho et al., 2008; Yan
et al., 2005; Roussa and Krieglstein, 2004; Momcilovic et al.,
2012; Swistowski et al., 2010), possessed the potential to
specify cell fate, particularly to DPs. At 5 days after Oct4,
Sox2, Klf4, and c-Myc induction, the cells were further cultured
in the presence of SHH and FGF8 (Fig. 1A). Similar to the iNSC
reprogramming in which FGF2, EGF, and FGF4 were used,
under SHH- and FGF8-supplemented condition, colonies were
emerged from around day 10 and grown continuously until the
isolation on day 13 (Fig. 1B). We compared these two
approaches to investigate how the different environmental
conditions affected the reprogramming. Surprisingly, the
marker genes of ventral midbrain dopaminergic precursors,
such as Pax2, Lmx1a,Msx1, Ngn2, Foxa2, and Corin (Rhee et
al., 2011; Aguila et al., 2012; Roybon et al., 2008; Studer,
2012), were initially detected from day 7, only two days
after SHH and FGF8 supplementation, and distinctly
increased compared to iNSC reprogramming (Fig. 1C;
supplementary material Fig. S1). These results show that a
highly specific and rapid cell fate change to DPs can be
forced by the newly applied environmental factors SHH and
FGF8 (SF) in our PDR approach.
To determine the properties of the reprogrammed cells with
SHH and FGF8, we measured the amount of dopaminergic
neurons differentiated from the reprogrammed iDPs and iNSCs
under a serum-free differentiation condition. After 1–2 weeks
of spontaneous differentiation, the reprogrammed iDPs yielded
a higher proportion of TH+/TUJ1+ dopaminergic neurons
(26.9 ± 7.2%) than iNSCs (b3%) (Fig. 1D and E). These results
demonstrate that the reprogrammed iDPs are significantlymore
potent than iNSCs in generating dopaminergic neurons. In
summary, we were able to obtain iDPs with the PDR approach
under the DP-favorable condition containing SHH and FGF8.
Inhibition of Jak and Gsk3β enhanced the
reprogramming to iDPs
Although we could reprogram cells to iDPs, the efficiency of
differentiation to TH+ neurons from iDPs appeared to be
Figure 1 Direct reprogramming to dopaminergic neuronal progenitors through the temporal expression of pluripotent cell-specific
reprogramming factors. (A) A schematic of the direct reprogramming of reprogrammable mouse embryonic fibroblasts to induced
dopaminergic neuronal progenitors (iDPs). Induction of the four reprogramming factors for five days and subsequent exposure to SHH
and FGF8 enabled the conversion to iDPs. (B) Bright-field images of direct reprogramming to iDPs on the designated day. Scale bars =
100 μm. (C) Gene expression analysis showed that the major midbrain dopaminergic neuronal progenitor markers (Foxa2, Lmx1a, and
Ngn2) were differentially expressed during the direct reprogramming to iDPs and to induced neural stem cells (iNSCs). All the values
are relative to day 0. Mean ± s.e.m. (n = 3–5). (D) Immunocytochemical analysis of terminally differentiated cells from iNSCs or iDPs.
The dopaminergic neuronal marker (TH, red)-expressing cells were more abundant in the cells differentiated from iDPs. The neuronal
marker TUJ1 is shown in green. Scale bars = 100 μm. (E) The percentage of TH-expressing neurons of the TUJ1-expressing neurons
was calculated. Mean ± s.e.m. (n = 6), p b 0.01.
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onic stem cells (ESCs) (Momcilovic et al., 2012). Thus, to
increase the efficiency of the process, we inhibited Jak–Stat
signaling as in the PDR to induced cardiomyocytes, whereby
a Jak–specific small molecule inhibitor increased the repro-
gramming efficiency (Efe et al., 2011). We hypothesized
that inhibition of the Jak–Stat pathway, which is important
for self-renewal of ESCs and reprogramming to pluripotency
(Kim et al., 2011a, 2012; Efe et al., 2011; Efe and Ding,2011a, 2011b; van Oosten et al., 2012; Yang et al., 2010),
would enrich the pool of intermediate cells which can be
destined to iDPs by blocking the alternative path to the
pluripotent state. As expected, temporal Jak inhibitor 1
(JI1) treatment from day 5 to day 7 significantly increased
the expression of dopaminergic marker genes, such as En1,
Lmx1a, FoxA2, and Corin, compared to untreated controls
(Fig. 2A). Using immunocytochemistry, we also determined
that En1-expressing cells were markedly increased in the
Figure 2 Enhancement of direct reprogramming to iDPs by Jak and Gsk3β inhibition. (A) Quantitative PCR analysis shows that the
expressions of DP markers were increased by Jak inhibitor 1 (JI1) treatment from day 5 to day 7. EGF, FGF2, and FGF4 (EFF) were
treated for iNSCs and SHH and FGF8 (SF) for iDPs. All the values are relative to iNSCs. (B) Immunocytochemical analysis shows
increased En1 (a midbrain DP marker)-expressing cells by the JI1 treatment. Scale bars = 50 μm. (C, D) Quantitative PCR analysis of
Corin, a representative DP marker, on day 13 to find optimal duration and concentration of CT99021 (CT) treatment over SF + JI1
treatment as in panel A. (C) 0.5 μM CT was treated from the indicated day until day 12. (D) Different concentrations (μM) of CT were
treated from day 10 to day 12. All the values are relative to basal SF + JI1 treatment. Mean ± s.e.m. (n = 3), p b 0.01 (*), p b 0.001
(**). A statistical analysis was performed using Student's t-test.
64 H.-S. Kim et al.JI1-treated iDP population (Fig. 2B). Thus, we concluded
that inhibition of Jak–Stat signaling in the intermediate cells
is effective in enhancing the efficiency of direct repro-
gramming to iDPs.
Second, we considered the contribution of Wnt signaling,
which is important in the early (E9.5–E10.5) and late (E11.5–
E12.5) stages of ventral midbrain dopaminergic neuronal
development (Momcilovic et al., 2012; Prakash et al., 2006)
and the differentiation of hESCs or iPSCs to dopaminergic
neurons (Kirkeby et al., 2012; Kriks et al., 2011; Chung et al.,
2009). We applied a specific inhibitor of Gsk3β, CT99021 (CT),
to activate Wnt signaling and assessed with Corin expression,
the most reliable marker of midbrain dopaminergic progenitors
(Chung et al., 2011; Xi et al., 2012; Jonsson et al., 2009). We
found an optimum time-frame and concentration of CT
treatment to enhance the efficiency of reprogramming to
iDPs (Fig. 2C and D). These results are similar to previous
reports, in which both a specific concentration of CT and a
particular time window of CT administration were necessary
for specification to midbrain cells (Kirkeby et al., 2012; Xi et
al., 2012). Additionally, Corin-expressing cells were only
detectable in the JI1- and CT-treated cultures on day 13
(supplementary material Fig. S2). In summary, we found
that combined inhibition of Jak and Gsk3β significantly
enhanced the process of DP specification during our direct
reprogramming. In addition, the concentration and time-window of CT treatment need to be finely optimized to
obtain the highest reprogramming efficiency.iDPs can self-renew and generate functional ventral
midbrain dopaminergic neurons
After we optimized iDP generation (Fig. 3A), we analyzed the
characteristics of the dopaminergic neurons differentiated
from the iDPs to prove the functionality of our reprogrammed
iDPs. Most of the TH-expressing dopaminergic neurons co-
stained with ventral midbrain precursor markers (FoxA2 and
Lmx1a) and midbrain dopaminergic neuronal markers (Nurr1,
En1, and Pitx3) (Studer, 2012) (Fig. 3B and supplementary
material Fig. S3A), confirming that the differentiated dopami-
nergic neurons manifest midbrain specificity. We also showed
that the JI1-treated iDPs generated 44.3 ± 8.4% TH+/TUJ1+
neurons and the JI1 and CT co-treated iDPs generated 57.2 ±
7.2% TH+/TUJ1+ neurons (Fig. 3C; supplementary material
Fig. S3B), confirming that the reprogramming efficiency to iDPs
is actually increased by the combined treatment. To assess
whether the generated TH-expressing neurons are functional
dopaminergic neurons, we measured the level of released
dopamine in the culture medium. As expected, the neurons
from iDPs of higher reprogramming efficiency released even
more dopamine than other samples (Fig. 3D) and these
Figure 3 The iDPs were differentiated into typical ventral midbrain dopaminergic neurons. (A) A schematic of the optimized
protocol for direct reprogramming into iDPs. (B) Immunocytochemical analysis of dopaminergic neuronal makers, such as TH and
Nurr1, in the differentiated neurons derived from the CT- and JI1-treated iDPs. Scale bars = 50 μm. (C) The percentages of TH+
neurons of the total neurons (TUJ1+) differentiated from the reprogrammed cells under various conditions were analyzed by
immunocytochemistry. Mean ± s.e.m. (n = 7–10), p b 0.001 (**). (D) Measurement of released dopamine after the treatment of low
(LK) and high (HK) concentration of KCl on the differentiated cells from designated reprogrammed cells. (E) The representative traces
of membrane potential changes and action potentials (Aps) elicited by step-current injections before and after an application of TTX.
(F) Example trace of a cell exhibiting spontaneous APs at resting membrane potential. (G) Example trace of a cell showing rebound
depolarizations.
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solution (HK), a depolarizing condition. These results represent
that the generated neurons from iDPs are functional dopami-
nergic neurons which show responsive release of dopamine.
Finally, we analyzed the electrophysiological properties of the
neurons from iDPs. Under a current-clamp configuration,
depolarizing current injections with 10-pA steps induced
action potentials (APs) in ~42% of recorded cells (11/26
cells) (Fig. 3E). The generation of APs were blocked byTTX treatment, indicating its dependency on voltage-gated
sodium channels. A majority of cells (9/11 cells) showing
APs also exhibited spontaneous firings (Fig. 3F) and rebound
depolarizations resulting in AP generation after short hyper-
polarizations (Fig. 3G), which are characteristics of midbrain
dopamine neurons (Grace and Onn, 1989). The electrophysi-
ological properties of differentiated cells from iDPs were
described in supplementary material Table S1. We also tested
whether the iDPs could self-renew in vitro. As previously
Figure 4 Adult mouse tail tip fibroblasts were directly reprogrammed into iDPs (A) Immunocytochemical analysis of terminally
differentiated cells from TTF-iNSCs or TTF-iDPs. The TH-expressing cells (red) were more abundant in the cells differentiated from
TTF-iDPs. Scale bars = 100 μm. (B) The percentage of TH-expressing neurons of total neurons (TUJ1+) differentiated from iNSCs and
iDPs. A statistical analysis was performed using Student's t-test. Mean ± s.e.m., p b 0.01 (*). (C) Immunocytochemical analysis of
midbrain dopaminergic neuronal markers in differentiated neurons. The TH+ (green) neurons expressed dopaminergic neuronal
markers (red), such as Foxa2, Pitx3, and En1. Scale bars = 50 μm.
66 H.-S. Kim et al.reported (Chung et al., 2011), under FGF2 containing culture
condition, the Corin-expressing progenitors were increased
(Fig. S4A) and showed co-expression with Ki67, a marker for
proliferating cells (Fig. S4B). The Corin-expressing popula-
tion was maintained up to 16.22% by day 18 (Fig. S4C). These
results show that our directly reprogrammed iDPs are bona
fide progenitors which can generate functional and respon-
sive dopaminergic neurons of midbrain. Considering that
catecholaminergic neurons also express TH, our direct
reprogramming strategy to iDPs endorses a robust protocol
for generating the midbrain-specific dopaminergic neurons
which are required for potential cell therapy and drug
discovery for PD.Adult mouse tail tip fibroblasts are successfully
reprogrammed into iDPs
Lastly, we evaluated our direct reprogramming to iDPs
with mouse adult tail-tip fibroblasts (TTFs) using the Dox-
inducible STEMCCA system (Kim et al., 2011a; Sommer et al.,
2009) to prove our reprogramming strategy is also effectivewith
adult cells. As observed in iDPs from reprogrammable MEFs, we
found highly efficient differentiation into TH-expressing neu-
rons from TTF-iDPs compared to TTF-iNSCs (Fig. 4A and B).
These TH-expressing neurons also expressed midbrain-specific
markers, such as En1, FoxA2, and Pitx3 confirming the
specification to midbrain DA neurons (Fig. 4C). Thus, adult
mouse fibroblasts can be efficiently reprogrammed into
ventral midbrain iDPs by our PDR strategy.Conclusions
Recently, several groups reported direct conversion of
fibroblasts into dopaminergic neurons (Pfisterer et al.,
2011; Caiazzo et al., 2011; Liu et al., 2012b; Kim et al.,
2011b), where the resulting cells are non-proliferating
terminally differentiated neurons. We demonstrated here
that mouse fibroblasts can be directly reprogrammed to
functional and proliferating midbrain DPs through cell
activation by pluripotency factors and directed specifica-
tion by signal factors including SHH and FGF8. The
trajectory of iDP reprogramming is traced as different
from iNSC reprogramming. We were able to finely tune the
process to increase the efficiency by co-inhibition of Jak
and Gsk3β. The iDPs are functional and proliferating
progenitors which give rise to typical midbrain dopami-
nergic neurons. We expect that our PDR strategy is not only
applicable for iDP generation but also for direct lineage
reprogramming to other progenitors which are required for
various neural diseases.
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